Sana Biotechnology
SANA
2.70
-0.02
-0.74%
Sana Biotechnology
US · SANA
#3404 by market cap
Listed 2021
2.70
-0.02
-0.74%
Live - 5344 symbols - heartbeat 266s ago
· 2026-10-08 09:59
Pre-market
2.72
0.00%
After-hours
2.80
+2.94%
Overnight
2.77
+1.84%
- Market cap
- 808.27M
- P/E (TTM)i
- -3.60
- P/Bi
- 5.23
- EPSi
- -0.96
- Div yieldi
- 0.00%
- 52W posi
- 2%
Reader sentiment
Are you bullish or bearish on SANA?
Anonymous reader poll. Unscientific, not investment advice.
About Sana Biotechnology
Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses on identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 2018 and is headquartered in Seattle, WA.
- Founded
- 2018
- CEO
- Dr. Steven D. Harr, M.D.
- Employees
- 142
- Headquarters
- Seattle, Washington, United States of America
- Fiscal year end
- 12-31
- Website
- sana.com
Company profile
- Exchange
- US
- Symbol
- SANA
- Market-cap rank
- #3404
- Listing date
- 2021-02-04
- Market cap
- 808.27M
- Float cap
- 515.39M
- Shares out
- 299.36M
- Float shares
- 190.89M
Sectors & themes
Quote time 2026-10-08 09:59:55 · For reference only, not investment advice and not tailored to your situation.